Clinical Trial Update: Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer [EARLY_Phase 1]

View source ↗

Summary

This document reports an early-stage Phase 1 trial at UNC evaluating autologous CAR T-cells targeting the GD2 antigen for lung cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• GD2-targeted autologous CAR T cells (CAR T cells targeting GD2)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Lung Cancer, Small Cell Lung Carcinoma | EARLY_Phase 1 | Status: RECRUITING